Replies to post #105547 on NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

Per post 105519, md indicated

As soon as PFS endpoint was reached the process of data lock begins
as each death is reached that data point is locked
I was told waiting could be many many months
or the FDA could halt for efficacy at their discretion if overwhelming efficacy seen.
Otherwise once 231 is reached it would be a matter of days to get to topline data.

This is very confusing, especially since he does not separate sentences well.

So is he saying ... things could take months after PFS endpoint is reached .... well ... NWBO already stated this in a PR. And we are already quite some time into the process after PFS events reached ... hopefully making progress.

And I think he is indicating that while the PFS events verification process is taking place, that each patient death in the P3 study is still tabulated ... but this is as easy as pie to keep track off ... and once the OS of 231 events is reached, then we should not have to wait for months, but rather likely just for days?

And ... FDA could make things happen even sooner ... at their discretion.

MD ... is the above a correct interpretation ... or would you like to add more clarity?
So how soon do you think we could see topline results, md? Perhaps middle of March or end of March? April?